Reddit Posts
Do y’all think the Autonomix (NASDAQ: AMIX) IPO tomorrow has the potential to be the TOP IPO of 2024?
EBYH - "We are thrilled to conclude 2023 with our most substantial orders to date".
If an acquisition is announced at $X/share, why would anyone sell it for LESS?!
Individual stocks vs ETF vs REIT vs Robo-investing
BNOX - Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
$NRXS IBS treatment with less side effects than their competitors
Is having a money manager/"Private CFO" worth it?
What would you buy for a short-term medium risk profit expectation right now? Would you sell your most disappointing stock to buy that?
How do I decide between initating a new position vs adding to an existing one?
Looking for help on when to initiate a new position vs DCA an existing one?
Time to dump tech and buy dividend stocks?
Pharmaceuticals break COVID lows trend line signaling end to Bear Market
AbbVie down 7%. Humira sales down 25% As Biosimilars Hammer Away At Sales
AbbVie gains as Skyrizi succeeds in ulcerative colitis (NYSE:ABBV)
2023-02-27 Wrinkle-brain Plays (Mathematically derived options plays)
AbbVie sued in Netherlands for breaching human rights over Humira pricing (NYSE:ABBV)
Next big wave of patent cliffs ahead; expect biopharma M&A to rise (NYSE:ABBV)
$BIOR rising on short squeeze lists. Currently only $30M market cap... Imagine would it could be worth to ABBV as a way to regain patent protection on Humira... explains current $65 price target. Could run incredibly high...
The investor who bought 2.1 Million shares the last session is $7,035,000.00 wealthier in just 24 hours
My short, intermediate, &long and good divident stock reversal confirmed. Shortsqueeze and gamma squeeze (score 87) is a real possibility
AbbVie sets outlook below consensus amid generic threat to best selling drug (NYSE:ABBV)
AbbVie pins hopes on newer drugs and deals to face Humira knockoffs (NYSE:ABBV)
Drug price inflation continues upward momentum at 3.8% – report (NYSE:ABBV)
U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates (NYSE:ABBV)
AbbVie’s global bestseller Humira to face knockoffs this week (NYSE:ABBV)
My 2022 strategy been working well I guess ¯\_(ツ)_/¯
What are some good healthcare stocks to hold long-term?
Shorting ABBV: Machine Learning Model.
Looking for some constructive advice on my Roth portfolio. What would you cut to get this down to an even 10 stocks?
Why are people throwing money at TEVA after the recent Supreme Court ruling?
Birth control-related pharma plays $OGN $ABBV $TEVA $JNJ
Birth Control-related Pharma Plays $OGN $ABBV $TEVA $JNJ
What did you bought today? Just got some BMO and JPM pretty cheap myself!
$ABBV which trades at $140 has a stake in $XCUR which trades at 18 cents - they are partnered and its all confirmed in partners earnings call. I’ve been going through everything trying to figure out why this is so low and can’t rationalize it. Has .69 cash per share as well.
$XCUR - go through Ipsens Feb 2022 presentation - the partnership with $IPSEY is legit this was at $2 when it was announced. $ABBV must be legit as well:
$XCUR - go through Ipsens Feb 2022 presentation - the partnership with $IPSEY is legit this was at $2 when it was announced. $ABBV must be legit as well:
$XCUR it’s all fucking legit with $ABBV and $IPSEY cant believe it’s at .18 cents. It’s all confirmed on Ipsens earnings call four days ago.
Some big news on $XCUR in most recent $IPSEY Earnings Call they stated the partnerships are continuing. Which means $ABBV partnership still intact. This could be the $BNGO of this year running pennies to dollars.
If you only had to hold a few individual stocks, which would you choose? Or just throw everything in ETFs?
Fat bids on $XCUR all afternoon don’t think this is done. Maybe the partnership with $ABBV and $IPSEY are legit. They just have a shit CEO rn
Big picture on $XCUR is average cost is .80 and PTs range from .40-$6 I just think these prices won’t ever come back. Going long for better or worse but $ABBV partnership isn’t something that can be ignored the Chairman is the CEO of $HZNP
$XCUR - risky play but high risk high reward! The latest filing states the partnerships with ABBV and IPSEY are going fully ahead:
When Partnership news hits $XCUR it’s going straight to $1 at minimum. There’s no way these prices stay this low. When $ABBV announced it ran to $3.30 this could be the next $BNGO pennies to dollars imo
When Partnership news hits $XCUR it’s going straight to $1 at minimum. There’s no way these prices stay this low. When $ABBV announced it ran to $3.30
Partnership news is what will send $XCUR up im holding from .16 waiting til news hits. The partnerships with $ABBV and $IPSEY took it from .90-$3.30 we should have neuroscience partnership news soon worth $1.9B
Partnership news is what will send $XCUR up im holding from .16 waiting til news hits. The partnerships with $ABBV and $IPSEY took it from .90-$3.30 we should have neuroscience partnership news soon worth $1.9B
The major pharma partnerships with $ABBV and $IPSEY make $XCUR extremely undervalued. I can’t wrap head around it under $1 in all honesty. Sorry if keep posting and it’s turned spammy - go through all the DD and make mind up. In my mind it doesn’t make sense when partners were announced it was $3.50
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades $24) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades $24) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades. $15) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR it’s partners trades at $140!!! $ABBV and $IPSEY. The CEO of $HZNP which trades at $90 is chairman of $XCUR - i think this is the next $BNGO and could potentially run to $10 - these partnerships aren’t a joke.
There’s a shit ton of naked shorts in $XCUR is nobody seeing this PA this could really go like $BNGO from pennies to $10+ these are some insane partnerships with major major pharma $ABBV trades at $140
$XCUR is a $PROG 2.0 - some warrants were issued at .01 but they haven’t redeemed the .27 warrants or the shares at .33 per Jan 2022 filing which would push the price to .50 minimum on execution. The neuroscience and pain partner will be announced in 2022 - it did a 60% move on IPSEN and $ABBV news:
$XCUR (currently 16 cents) - $ABBV and $IPSEY 1B Partnership Breakdown:
When $XCUR first IPO’d they issued it a $9 PT the fact it’s 16 cents now is unbelievable with an $ABBV and $IPSEY partnership. If you’re able to buy 100k shares rn and sit for a year or two it’s an easy 5-10X money imo.
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR is very interesting down here partnered with $ABBV
How many of you use leverage or borrowed money to boost your portfolios?
Stocks you can’t wait to see dip because you’re itching to buy them
ABBV Valuation from $111 to $172...just like that huh?
ABBV Valuation from $111 to $172...just like that huh?
Buyout Coming Soon ABBV. Buy all you can, once in a Lifetime here
Earnings for this week & Next week (Me, ABBV, AMC, APPL, etc….)
Stock picks for a 10 year hold with the hope of 5x my money...which ones?
$ABBV short term calls Gain with more to come after Friday announcement with RGNX! Here we go!!!
Let's try $ABBV short term calls. Retina meeting this Friday. Data hopefully is good 10/8 high risk high reward calls. YOLO!
The Cutting Edge: $ATNF, $ABBV, and Adalimumab
Mentions
Join my tictok @Devinbaily99 I post sna I shots of my leading stocks and share what's working for me. Some of my biggest % gains over past few years has been META NVDA ABBV CLH CAT <________________ I also recommend an index and let it run till retirement fir the compounded interest. -Devin
best part is that doesnt matter if this works or not, it will get bought out by ABBV and the OP will be a millionare
PUTS on NKE, SBUX, INTC, and ABBV. Otherwise pickings be slim at this point since UNH ran it’s course
Someone please save ABBV 
they were down, very early morning (maybe futures only I’m not sure yet what I saw) but VRTX, ABBV, LLY and JNJ were definitely down, and I think many more. I was eager to buy calls on them because this EO will not execute, and once people realized that, the stocks will just go up again. But I was also researching some other stock. I looked at the stocks in the afternoon, and they were already up again. So I just left kt
Lol $ABBV 
Whichever one dips the most PFE, JNJ, MRK, ABBV, BMY, AMGN, GILD, NVS, SNY
My ABBV calls are cooked if what this retard says actually moved pharma
Nice, that's a cool idea. I'm probably buying CATL at its introduction on the HK exchange. A couple of other funny non US bets of mine you could follow, for the fun of it. ABB (ABB.ST), ATCO (ACO-X.TO), Kaspi.kz (KSPI Nasdaq), Reliance Industries (RIDGL.XC) and Tryg a/s (TRYG.CO) Set a reminder for a few years and come rub my face in it, when the US had kept out performing the rest of the world yet again. To make it worse, I sold ABBV, SO, CSCO, LMT, NOC, GLW and TXN in January, to cut my US exposure in half. Dumped most in my mortgage and the rest went into ABB, RIO and Reliance. At this point it seems nearly prescient, given how the USD has crashed, though I assure you it is pure luck.
So... Trump going to cause death and suffering. Just like last time. Fyi, I still have no idea how Eli lilly is going to find the money for its announcement of $50 billion in US manufacturing. https://finance.yahoo.com/quote/LLY/balance-sheet/ It's definitely not coming from inside the company with a balance sheet like that and are they really going to take billions of corporate bonds out in the tune of potentially 6-7% as US Treasury yields spike? They're already paying 5.74%. ABBV is paying 6.0%.
Hey guys! Trading Recap (4/29/25) 💯 12 for 16 = 75% ✅ Hits: $WW (x4), $ABVE, $NVNI, $ABAT, $OMH, $WOLF, $PLUG, $PE, ABBV (options call)
I’m recommending the ABBV 180 calls for May 16 if you wanna chase here
Fuck yeah homie. I sold all my calls at close today. Not holding through earnings. I did see a lot of call buying in out of the money calls expiring tomorrow that we're buy to open because the volume was higher than the open interest. Looking at the after hours trading in ABBV It was a mistake to sell those calls but you just never know and I've gotten destroyed by holding options through earnings. Hopefully ABBV rips up 20% tomorrow haha.
!banbet ABBV 170 16h
I believe it’s ABBV that owns Durata via them buying Allwergan
I listened to some regard on the earnings page and bought ABBV puts before close. Lets see how fucked I am.
+140% ABBV calls aaaaand I’m holding til tomorrow
https://preview.redd.it/2nf7na621uwe1.jpeg?width=1440&format=pjpg&auto=webp&s=aee9f90fa5010a6ca3ed3c645f5a912e04aa9f1c ABBV calls expiring tomorrow executed at the ask. Volume greater than open interest 👀. Earnings tomorrow at 730AM
Anyone playing ABBV? Health stocks haven't been doing so hot recently so I'm thinking puts
Whats a good Google 1dte option to play? And maybe ABBV?
https://preview.redd.it/1ouvhivawrwe1.jpeg?width=1440&format=pjpg&auto=webp&s=a036ad69622276d0b3ebcf93ba31ac66c196876e 11 $180.00 calls and two $190.00 calls. I am selling before close however because I hate holding through earnings and having a winner turn into a loser. Full disclosure. I think $ABBV will close above $179.00 today.
https://preview.redd.it/w63toxqivrwe1.jpeg?width=1440&format=pjpg&auto=webp&s=d2ae5623e112fa94f86ebdeb209c8cce914470c5 11 $180.00 calls and two $190.00 calls. I am selling before close however because I hate holding through earnings and having a winner turn into a loser. Full disclosure. I think $ABBV will close above $179.00 today.
If what prints? The earnings, $ABBV stock, $ABBV calls?
$ABBV has a large US manufacturing presence that will mitigate most of the tariffs. The majority of their manufacturing is done domestically.
Buy $ABBV stock and $ABBV 4/25/2025 calls today. $ABBV reports earnings tomorrow @ 07:35 AM. ABBV has a P/E ratio of 14.5 and prints cash. Revenue from drugs Skyrizi and Rinvoq are projected to exceed $30 billion by 2027.
Buy ABBV 4/25 CALLS BEFORE CLOSE FOR EARNINGS RELEASE FRIDAY
I am closing my $ABBV calls at close most likely and depending on where we're at EOD, buying SPX Puts 1DTE
https://preview.redd.it/ft1ljnq8lfwe1.png?width=1440&format=png&auto=webp&s=a495ab445536af5d2b1df903a820b4299628bbf6 POSITIONS: 11 ABBV $180.00 4/25 CALLS 2 ABBV $190.00 4/25 CALLS
What was your reason for buying ABBV calls? I have 09/19 $200. I see it’s bounced off a 7 year trend line.
Whats you plan for ABBV calls? I wanna take a position and play the earnings but with shares
Do you have an example of a spread that went well for you that you can post? I did well on things like ABBV because I saw the overreaction in November and rode it up, but I did panic on the short legs and failed in execution I appreciate the insight, if you have even a small, simplistic example from opening to closing that would be extremely helpful
The question is stroked with a broad brush. Is there one? Probably not. Few stocks can stand the test of time. If you asked me in 2016 this question the same dividend stocks I suggested then I would today. ABBV has top-notch management that is loyal to shareholders with annual dividend increases. The other would be for a taxable account. EPD is an MLP so you have a K-1 if that is an issue.
Instead of providing exit liquidity, grab up MRK, BMY, JNJ, PFE, ABBV, and actually get rich cause these are the type of players with the actual money to benefit from AI drug discovery, and you can bet that they already are researching it.
For awhile I was sitting kind of smug with my barely effected Boomer stocks ($ABBV, my Botox darling) but then they came for my geriatric shit and there was no one left to speak for me.
A years worth of growth is already gone from ABBV.
oh yeah dude totally. pick up 1 at a time and think about it. typically i just look at the history of the swings of the contracts and then i try to start applying the fundamentals of the underlying. if i see anything that is compounding my conviction maybe I will jump in with a few hundred but honestly, a lot of the plays are scattered out $3 $5 $10 $20, $30, $50 contracts. And when the price moves against me, but I actually WANT that position, great, I'm only in for 1 contract, maybe I'll buy 2 more now, if I'm hearing things that make my thesis for that investment increasingly durable. ABBV after the election, mega dropped, I felt that was an overreaction so I bought a far dated put for $30. It moved towards my strike and appeared as if it was going to fill the gap so I decided to add to it continuously,-> as the new premium was actually lowering my cost basis considerably. I think I added 20 contracts for $3 each at one point, and when it closed the gap the contracts swelled right back up, past the $30 mark into the high $40s. ***and then of course, if you don't believe in something, just don't add to the position,*** or better off, sell that shit and get your loose dollars back. you don't ***have*** to watch any contract go to 0 if you don't want to
JPM,HOOD, GE, ABBV, 180, 25, 120, 120 If those stocks get to this price points I’m throwing my cash at them. That’s me tho
This is a great buying opportunity, I’ll be buying up quality stocks like Apple, CVX and ABBV at great discounts. If they keep going down , I’ll keep buying.
ABBV has been doing great these couple weeks. Also a small amount of CL and KHC. Dividend stocks are holding their own recently
BRK.B, PPL, ABBV, GSK, MRK, MMM OXY, T, VZ & XLU. Ugly day overall.
Oof that sucks :/ I'm in a similar situation, my stocks were doing pretty well in January. Now my only stocks that are doing well are Colgate and TSLZ (-2x inverse leveraged Tesla) lol and ABBV
Pharma like ABT and ABBV up recently too…putting money in safe spots.
have you guys considered that youre in shit stocks? my stocks are split, notables today are: ABBV, CLX, ES, GD, HD, IBM, OKE, XOM.
Tech/Corn bros are cooked. Can’t find job. No alt season. Everyone is forced to buy freaking ABBV 🤡
Growth stocks go up fast and go down faster. The market regime has shifted to risk-off. RDDT’s drop is in line with many of the growth stocks like HOOD, APP, HIMS, OKLO, etc. But zoom out, RDDT is still at November prices. I know you may see a big drop, but I see this as more of a reversion to the mean from an overheated rally In the future, you can keep an eye out on how defensive stocks are doing. We clearly have seen a rotation out of growth stocks to defensive stocks. Stocks like T, VZ, MCD, KO, ABBV are making ATH almost daily in this market
In 2020 I went to 100% cash in the third week of January. I started buying way out of the money puts on cruise lines, airlines, hotel chains. Most of these paid between 50x to 100x. I opened some shorts recently I have a good amount of SQQQ for example. I also shorted some of the mag7. I bought defensives like PG, AMGN, ABBV, JNJ. I also day trade. Grew that account by 20% in the last few weeks. Mostly TSLA and PLTR both on the up and down sides.
I have a lot of Google already, and ABBV has an 88 PE ratio (no idea what the forward PE means here because the trailing is increasing over time).
I'll check ABBV out. That's interesting for sure!
ABBV was up $3 today while the rest of my portfolio is pretty much a sea of red.
CNQ in the mid $20's with a 5.8% yield and very good (as energy companies go) management is an example of something that I'm fine continuing to nibble on if it goes lower and reinvest dividends. CNI would be interesting in the mid $90's. Some of the European alcohol names are trading as if people aren't going to drink again - Remy Cointreau, for example. Yes, the alcohol names are absolutely facing headwinds, but something higher end like Remy down 80% off the high is compelling enough to start a small position and perhaps there's eventually consolidation. Would be thrilled to get another chance to add to some of the trash collection names and perhaps if you get even a brief risk on window again some more defensive names come down. Along the same lines, ABBV currently has an RSI in the 80's and is way overbought; would be interested in that starting if it gets back under $200. The IPP names (VST, CEG, TLN, etc) aren't something I'd pile into but are starting to get interesting again. I think there's a decent amount on the shopping list and I continue to gradually - emphasis on gradually - buy. That said, I am trying to create more of a mix of growth and value/core and I think that's how I see things staying for the foreseeable future: a portfolio that leans growth but spans everything from value to a handful of smaller positions in selected very speculative growth.
Obviously the European defense companies, although those have gone up in a manner where I wouldn't be surprised if there was a minor correction but that would be a buying opportunity. Kongsberg Gruppen is another name in this category that I've never seen anyone mention. Galderma is an interesting one - dermatology platform company with injectable asthetics (a la ABBV's Botox-lead Allergan), therapeutic dermatology (Rx for skin conditions) and skincare (lotions, etc.) Sandoz is the largest generic pharma co and has done well since spinning out of Novartis. Steady/consistent/relatively boring business in general, but opportunity in the coming years w/GLP-1 as semaglutide gradually starts to see patents expire in various countries. There's of course the luxury/high end luxury names but IMO the time to really buy some of those was late last year.
ABBV bears stay strong  way overbought right now
Thank god I decided to buy puts on ABBV
ABBV and ABT just like last time
I started buying ABBV a few months ago at 171.00 its been on steady climb up ever since.
Higher quality large cap pharma (JNJ, ABBV) is generally recession resistant but not recession proof. Biotech (generally small/mid/early stage biotechs in particular that often require funding given many are not profitable) is not a good place to be in a recession.
I bought my PFE in 2008, I paid about $15 a share. In nearly 20 years I must have collected $30 a share in dividends, and the stock continues to pay $1.72 a year. I am really quite happy with it. I've also got ABBV, I paid $38 a share.
ABT and ABBV sailing above all the waves. Sick people aren’t affected by tariffs.
ABT and ABBV rockin’ it! Tariffs do nothing to sick people!
ABT and ABBV sitting just fine! Always gonna be sick people no matter what inflation and tariffs do.
ABBV, BRKB, JNJ in the taxable. For etf’s it’s SCHD, SGOV and FBND. I’ve also substantially trimmed my spec names which I trade in the Roth accts and put the proceeds half into SGOV for dry powder if there’s a sell off and half into resi REITs in the Ira’s and half into mlp WES in the taxable. Half the Roths are still regular index stuff. I’m also 55 yrs so dialing down the risk a bit.
Yes - BUT. I have 4 accounts. My 2 largest accounts I don't touch (except once to rebalance over a decade) and are ETFs only. In the other 2 I have a basic core that I keep and don't sell unless they are obviously going bankrupt or something which is unlikely. Right now that's AMZN, NVDA, WMT, ABBV, GOOG and LB in larger positions. I try to have a mix but those consumer stocks and VCR are doing great right now. Lots of tech exposure already in the 2 big untouchable accts.
I have *most* of my money in ETFs and got lucky with the Vanguard Technology ETF over the past several years. Since I'm old I diversified into bonds and added a small cap ETF recently because small caps have underperformed over the past several years. It's time for that pendalum to swing. That's my 403B. I have a ROTH with core positions in VCR, VOOG, Amazon, Walmart, ABBV and added BABA last month. (I just love BABA and always have, I had to cut it loose when it fell a couple years ago). I also have a *fun* account I trade options in with core positions in VGT and NVDA. My highest convictions right now are HIMS and NBIS. I also like ZBRA and have been waiting for it to fall, which it just did. We'll see where things go. HIMS earnings is this week so it'll run up, but who knows after. Personally I think it's a gold mine and will blow out earnings and run further up, but I have been wrong before. TEM looks really good also but it's volatile so if I decide to jump back in I'm waiting for a bad market day. Those AI health care stocks seem to be doing well. I like to buy LEAPS with options in my fun acct. This gives me a lot of time to become profitable, but I don't necessarily keep until close to expiry. I only play around (options) with about 40k or so. I will never make a million in a week like some on here, but I won't lose a million either. I have fun and keep my losses minimal. I have a deal with myself that when I turn a nice profit (up 50%) I sell a few of whatever stock or option that is and buy more VCR, VGT or VOOG. I don't ever sell the ETFs or core positions in Amazon, Walmart, ABBV, NVDA and now hopefully BABA as long as it continues to show strength. If I need funds I have to sell another stock or add money. IMO, putting a % of my winner stocks into the ETFs and NOT SELLING THE CORE POSITION STOCKS are the keys to success.
Planning for 10 more years. 1/3 ABBV for div, 1/3 ABT and 1/3 in S&P 500 fund. No cash yet. Minimal amount in a Roth for eventual rollovers.
Right, but why does it have to be one stock? ABBV pays 3.7% (pharma). MO pays 7% (consumer). NLY pays 13% (reit). And SHEL pays 4%. All different sectors but dividends remain high, so it spreads out your risk. That's all I'm suggesting. (Not necessarily those exact stocks. Not financial advice)
I own the usual suspects MCD, KO, PEP, LMT, AFL, MO, BMY, ABBV, AMGN, WMT, O, basically anything that pays and grows a dividend. I would build it up to $30K - $40K, reinvest the dividend, then start building the next position.
Hard to know the bottoms and margin can be dangerous on a falling market. I used margin for years to play the dividend harvest game. Would make about 2k a quarter off ABBV. It was a little bit of work, but some pucker. I would buy 1000 shares just prior to the EX div date. Sometimes the stock would go up more than the dividend, and I would sell it.
I do t know about the specific case of ABBV, I’m assuming they want to realize some synergy effects of combing the 2 companies, that might take a while. After a while the market might see the numbers and ABBV might go up. But basically the acquisition means there won’t be as much dividend payment as expected for a while, but long term it might the right decision for investors.
Not all bad news is bad news. ABBV got clobbered when they announced they were buying Allergan, the stock dropped 15%, a new 52 week low. I bought a truckload. I had owned ABBV twice before. Unlike T, they weren't out buying junk just to buy something. The current 52 week low is $153something. Another example is when a company reports less of an increase than the market expected/speculated. The stock gets a haircut of $3, $4, $8. If they still reported a healthy increase in sales and profits, just not the market's expectation, I may be buying. And those buys, I often hold only a few weeks because I am buying in an IRA where short term doesn't matter.
As a geezer \[born in 1949, I started investing at age 25\], my view is that there will be tension between two forces. First, Trump's emphasis on deregulation and his hate for government are "pro-business" for obvious reasons. It's likely to resemble a laissez faire economy. On the other hand, these policies are likely to be disastrous to the people and nation. Inflation, market imbalances, likely unemployment, etc. are probable. How does one navigate this turbulent sea? My approach (for what it's worth) is to stay invested, but to reposition some money. Have recently bought SLB, and have been shifting money from industrials into drug companies (PFE, ABBV, BMY) and utilities. Defensive stocks. However, my conviction stocks right now are GOOG and AMZN because they'll be around long after Trump is a horrible memory.
why ABBV up almost 10% on a miss?
Panic selling never does any good. Take it from me, I’ve done it a lot…. Wait, I think you just kept me from losing money on my ABBV 0DTE’s. Thanks!! I’m just gonna hold until it expires worthless!! 
Made a few 💰💰💰 on ABBV this morning. Total luck. 😆
No one talking about how ABBV is RIPPING
Looks like ABBV ER might have attracted some attention from the pharmaceutical sector 👀
ABBV beats on top and bottom lines and offers strong 2025 guidance. Stock up 4.2% 🎉
Mmmmm ABBV… 
I have basically clawed back all of my losses from the other day, and I am back to outperfoming the S&P YTD. Buying Vistra on the dip proved to be fruitful and I've just closed out my swing trade on TSM. Thinking I'll close out on ANET tomorrow. That said, what looks cheap in this market? I decided to sector rotate a bit into healthcare since it got punished to start the year. ABBV earnings are tomorrow, LLY on Feb 6, PFE on Feb 4, and SRPT on Feb 26. Bought PFE and SRPT as they are both trading at <10x Forward.
I did this for years. I have margin and the rate was so low I would buy 1000 shares right before the ex date, and sell it right after. I would get several thousands a year. I am in a larger tax bracket and it just made me pay more taxes. Generally the price absorbed the dividend, and I made a few bucks on the trade as well. It was ABBV years ago...it was in the 60s at the time and paid about 5% dividend. It was a stock I didn't mind owning if it dropped a little bit. You just have to watch out and not trade same stock in 30 days as it becomes a wash trade.
Pootz on ABBV XOM and UPS
So-called up and coming Bio stocks burn my ass every time I fall for em. Best to invest in established meds than emerging ones.. ABBV, MERK... PFE is pretty cheap at the moment. They pay hot dividends. Although that isn't a great reason to buy, to be honest. Lately I've been running away from dividend stocks. I really shouldn't be picking stocks at all. Because I'm a silly idiot. Just can't help myself.
buy 3 shares of ABBV in 1934 now worth 7.5M
That's great advice. I'd add: what are those 180s worth if ABBV closes at exactly 180 27 days from now? The answer is ZERO. We don't know what you paid for those, but *you need ABBV to be worth at least that much more* ***just to break even.*** Use that number in your decision. Strike + Premium = Breakeven That's the point at which you even barely start profiting. I have a personal rule that if a long Call is down 50% I sell it. (A mental stop-loss. I use 10% for stocks.) Best of luck, whatever you decide.
I'd rather recommend $ABBV in terms of pharmaceutical stocks. It has a good dividend yield with a solid history of raises and forward P/E of around 14 - 15.
I have different levels of entry which doesn't depend on the stock price but the quality more than anything else. If I am buying an AAPL, IBM, MSFT, NVDA, MRK, META, T I am buying at least $20k worth. If I hold for a long period I am adding to it. Then I have a buy on bad news level. CRWD was bad news purchase several weeks ago. I bought 40 shares for $278 and kept adding 10 more shares as it climbed back up. ABBV started out as a bad news purchase then they announced they were buying Allergan and the stock plummeted. I bought $15k worth and now have $34k from additions. Then there are my REITs. I buy them for the steady income, many of them pay monthly and I rarely own more than $5k of each though a few have climbed closer to $10k. They are speculative, volatile and I use the dividends to buy 4, 9, 15 more shares of my blue chips with the money. I pull the trigger when the stock drops to the low end of its range normally. The price per share only determines how many shares I get with the $5k, $10k or $20k I am investing. Hope that helps.
Too many to list. Shout out to CTRE, elderly care real estate might just fund my retirement. Moderna, Tesla, Crowdstrike, MyoCardia, ABBV, BRKB, CAVA, NET.
hi, i’m(24M) trying to diversify my portfolio as i feel that it is currently too Tech-centered. My time horizon is 10-15 years and beyond. Current portfolio % are: 65% between market based etfs like SPY and VWRA. 35% Mag7 stocks like NVDA,AAPL, GOOGL,META. Should i invest rebalance my portfolio with these? KO PG KHC BRK.b ABBV Thanks in advance for your valuable opinions!!!
NVDA, KO, AA, STLD, ABBV if I had to pick 5 for the rest of my life.
So originally I traded on E-Trade. I saved up 10k. I invested it into ABBV. Made 10K. =20k total at the time. Sold it and bought Palantir (PLTR) at $9-10. It went up to 80k-100k.. I transferred my account to Robinhood. I enabled margin. They gave me 100k to play with. I used the money that money to invest in more Palantir around 30.. and it kept rising. Then they gave me more margin. I used margin gains from every stock that i gained from to the next stock.. and now we're here.
LLY is great but its way too expensive. Same as ABBV. NVO was the only large cap that had a reasonable price. Have you looked at the companies and their numbers? Or just see weird tickers and assumed its a penny stock